US Patent 7138114 Pharmaceutical compositions of fibrinolytic agent

Patent 7138114 was granted and assigned to Amgen on November, 2006 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Amgen

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

71381140

Patent Inventor Names

Brian A. Peterson0

Brent S. Kendrick0

Date of Patent

November 21, 2006

Patent Application Number

102264080

Date Filed

August 23, 2002

Patent Primary Examiner

Nashaat T. Nashed

Patent abstract

Frozen and lyophilized compositions for a metalloproteinase fibrinolytic agent (fibrolase or NAT), a method for preparing the lyophilized composition, and a kit and method for reconstituting the lyophilized composition are described herein.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7138114 Pharmaceutical compositions of fibrinolytic agent

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API